Boston Scientific (NYSE:BSX) Updates FY24 Earnings Guidance

Boston Scientific (NYSE:BSX – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $2.29-2.34 for the period, compared to the consensus earnings per share estimate of $2.26. The company issued revenue guidance of +11-13% to ~$15.8-16.1 billion, compared to the consensus revenue estimate of $15.59 billion. […]

Related Keywords

Boston ,Massachusetts ,United States ,Wendy Carruthers ,John Bradley Sorenson ,Robertw Baird ,Boston Scientific Corporation ,Boston Scientific ,Needham Company ,Wells Fargo Company ,Get Free Report ,Wells Fargo ,Moderate Buy ,Bradley Sorenson ,Scientific Corporation ,Boston Scientific Daily ,Nyse Bsx ,Bsx ,Medical ,10113710 ,Guidance ,Earnings ,Preannouncement ,